Late-onset renal TMA and tubular injury in cobalamin C disease: a report of three cases and literature review
- PMID: 39390411
- PMCID: PMC11465495
- DOI: 10.1186/s12882-024-03774-w
Late-onset renal TMA and tubular injury in cobalamin C disease: a report of three cases and literature review
Abstract
Background: Mutation of MMACHC gene causes cobalamin C disease (cblC), an inherited metabolic disorder, which presents as combined methylmalonic aciduria (MMA-uria) and hyperhomocysteinaemia in clinical. Renal complications may also be present in patients with this inborn deficiency. The most common histological change is thrombotic microangiopathy (TMA). However, to our acknowledge, renal tubular injury in the late-onset presentation of cblC is rarely been reported. This study provides a detailed description of the characteristics of kidney disease in cblC deficiency, aiming to improve the early recognition of this treatable disease for clinical nephrologists.
Case presentation: Here we described three teenage patients who presented with hematuria, proteinuria, and hypertension in clinical presentation. They were diagnosed with renal involvement due to cblC deficiency after laboratory tests revealing elevated serum and urine homocysteine, renal biopsy showing TMA and tubular injury, along with genetic testing showing heterogeneous compound mutations in MMACHC. Hydroxocobalamin, betaine, and L-carnitine were administered to these patients. All of them got improved, with decreased homocysteine, controlled blood pressure, and kidney outcomes recovered.
Conclusions: The clinical diagnosis of cblC disease associated with kidney injury should be considered in patients with unclear TMA accompanied by a high concentration of serum homocysteine, even in teenagers or adults. Early diagnosis and timely intervention are vital to improving the prognosis of cobalamin C disease.
Clinical trial number: Not applicable.
Keywords: MMACHC; Cobalamin C disease; Homocystinuria; Renal tubular injury; Thrombotic microangiopathy.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
The roles of homocysteinemia and methylmalonic acidemia in kidney injury in atypical hemolytic uremic syndrome caused by cobalamin C deficiency.Pediatr Nephrol. 2022 Jun;37(6):1415-1418. doi: 10.1007/s00467-021-05372-6. Epub 2021 Dec 2. Pediatr Nephrol. 2022. PMID: 34854955 Free PMC article.
-
The MMACHC variant c.158T>C: Mild clinical and biochemical phenotypes and marked hydroxocobalamin response in cblC patients.Mol Genet Metab. 2024 May;142(1):108345. doi: 10.1016/j.ymgme.2024.108345. Epub 2024 Feb 10. Mol Genet Metab. 2024. PMID: 38387306
-
First Chinese case of successful pregnancy with combined methylmalonic aciduria and homocystinuria, cblC type.Brain Dev. 2015 Mar;37(3):286-91. doi: 10.1016/j.braindev.2014.06.007. Epub 2014 Jun 25. Brain Dev. 2015. PMID: 24974159
-
Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia: A case report and literature review.Medicine (Baltimore). 2017 Oct;96(43):e8284. doi: 10.1097/MD.0000000000008284. Medicine (Baltimore). 2017. PMID: 29068997 Free PMC article. Review.
-
Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.Pediatr Nephrol. 2017 May;32(5):733-741. doi: 10.1007/s00467-016-3399-0. Epub 2016 Jun 11. Pediatr Nephrol. 2017. PMID: 27289364 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources